36508083|t|Inhibition of glycogen synthase kinase-3-beta (GSK3beta) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.
36508083|a|GSK3beta has been proposed to have an essential role in Coronaviridae infections. Screening of a targeted library of GSK3beta inhibitors against both SARS-CoV-2 and HCoV-229E to identify broad-spectrum anti-Coronaviridae inhibitors resulted in the identification of a high proportion of active compounds with low toxicity to host cells. A selected lead compound, T-1686568, showed low micromolar, dose-dependent activity against SARS-CoV-2 and HCoV-229E. T-1686568 showed efficacy in viral-infected cultured cells and primary 2D organoids. T-1686568 also inhibited SARS-CoV-2 variants of concern Delta and Omicron. Importantly, while inhibition by T-1686568 resulted in the overall reduction of viral load and protein translation, GSK3beta inhibition resulted in cellular accumulation of the nucleocapsid protein relative to the spike protein. Following identification of potential phosphorylation sites of Coronaviridae nucleocapsid, protein kinase substrate profiling assays combined with Western blotting analysis of nine host kinases showed that the SARS-CoV-2 nucleocapsid could be phosphorylated by GSK3beta and PKCa. GSK3beta phosphorylated SARS-CoV-2 nucleocapsid on the S180/S184, S190/S194 and T198 phospho-sites, following previous priming in the adjacent S188, T198 and S206, respectively. Such inhibition presents a compelling target for broad-spectrum anti-Coronaviridae compound development, and underlies the mechanism of action of GSK3beta host-directed therapy against this class of obligate intracellular pathogens.
36508083	14	45	glycogen synthase kinase-3-beta	Gene	2932
36508083	47	55	GSK3beta	Gene	2932
36508083	64	76	nucleocapsid	Gene	43740575
36508083	97	107	SARS-CoV-2	Species	2697049
36508083	121	129	GSK3beta	Gene	2932
36508083	177	201	Coronaviridae infections	Disease	MESH:D003333
36508083	238	246	GSK3beta	Gene	2932
36508083	271	281	SARS-CoV-2	Species	2697049
36508083	286	295	HCoV-229E	Species	11137
36508083	434	442	toxicity	Disease	MESH:D064420
36508083	484	493	T-1686568	Chemical	-
36508083	550	560	SARS-CoV-2	Species	2697049
36508083	565	575	HCoV-229E.	Species	11137
36508083	576	585	T-1686568	Chemical	-
36508083	605	610	viral	Disease	MESH:D014777
36508083	661	670	T-1686568	Chemical	-
36508083	686	696	SARS-CoV-2	Species	2697049
36508083	769	778	T-1686568	Chemical	-
36508083	816	821	viral	Disease	MESH:D014777
36508083	852	860	GSK3beta	Gene	2932
36508083	913	925	nucleocapsid	Gene	43740575
36508083	1028	1041	Coronaviridae	Species	11118
36508083	1042	1054	nucleocapsid	Gene	43740575
36508083	1175	1185	SARS-CoV-2	Species	2697049
36508083	1186	1198	nucleocapsid	Gene	43740575
36508083	1226	1234	GSK3beta	Gene	2932
36508083	1239	1243	PKCa	Gene	5578
36508083	1245	1253	GSK3beta	Gene	2932
36508083	1269	1279	SARS-CoV-2	Species	2697049
36508083	1280	1292	nucleocapsid	Gene	43740575
36508083	1492	1505	Coronaviridae	Species	11118
36508083	1569	1577	GSK3beta	Gene	2932
36508083	Association	43740575	5578
36508083	Association	MESH:D003333	2932
36508083	Positive_Correlation	2932	43740575

